Aisling Capital IV, LP

Insider Reports History

Location
New York, NY
Signature
AISLING CAPITAL IV, LP, by Aisling Capital Partners IV, LP, its General Partner, by Aisling Capital Partners IV LLC, its General Partner, /s/ Andrew Schiff, Managing Member
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aisling Capital IV, LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Elevation Oncology, Inc. 10%+ Owner Stock Option (Right to Buy) 31,238 16 Jun 2023 Indirect

Insider Reports Filed by Aisling Capital IV, LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELEV Elevation Oncology, Inc. 16 Jun 2023 1 $0 4 10%+ Owner 21 Jun 2023, 16:09
ELEV Elevation Oncology, Inc. 17 Jun 2022 1 $0 4 10%+ Owner 22 Jun 2022, 18:43
ELEV Elevation Oncology, Inc. 29 Jun 2021 5 +$3,000,000 4 10%+ Owner 01 Jul 2021, 18:29
ELEV Elevation Oncology, Inc. 24 Jun 2021 1 $0 4 10%+ Owner 28 Jun 2021, 18:18
ELEV Elevation Oncology, Inc. 24 Jun 2021 0 $0 3 10%+ Owner 24 Jun 2021, 18:32